Formulation of beta cyclodextrin complexed controlled release matrix tablet of glipizide and its in-vitro evaluation

International Journal of PharmTech Research

Volumn 1, Issue 3, 2009, Pages 773-778

  Ashok V, Bhosale ^a   Sharwaree R, Hardikar ^a   Rajesh S, Jagtap ^a   Naresh B, Patil ^a   Sushant S, Dhawale ^a   Sanjay C, Shirsath ^a  

^a PDEA's Seth Govind Raghunath Sable College of Pharmacy   (India)

Author keywords

cyclodextrin; Glipizide; Inclusion complex; Matrix tablet; Poly ethylene oxide

Indexed keywords

BETA CYCLODEXTRIN; GLIPIZIDE; MACROGOL; PHOSPHATE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; IN VITRO STUDY; PHYSICAL CHEMISTRY; TABLET FORMULATION;

EID: 77953337661     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. nd Edn., Marcel Dekker, INC, New York and Basel: 4-6.
2. Khan G. M., Review, Controlled Release Oral Dosage Forms: Some Recent Advances in Matrix Type Drug Delivery Systems, The Sciences, 2001; 1(5): 350-354.
3. Wise D. L., In, Handbook of Pharmaceutical Controlled Release Technology, 2005; Marcel Dekker, INC., New York and Basel: 211, 435-440, 472-473, and 787-788.
4. P. Zimmet, Addressing the insulin resistance syndrome: a role for the thiazolidi-nediones, Trends Cardiovasc. Med. 12 (2002) 354-362.
5. A. Bhattacharyya, Treatment of type II diabetes mellitus, Hosp. Pharm. 8 (2001), 10-16.
6. V.H.K. Li, J.R. Robinson, V.H.L. Lee, Influence of drug properties and routes of drug administration of the design of sustained and controlled release systems, in: J.R.Robinson, V.H.L. Lee (Eds.), Controlled Drug Delivery - Fundamentals and Applications, (Drugs and the Pharmaceutical Sciences), 2nd, vol. 29, Marcel Dekker, Inc., New York, 1987, pp. 4-94.
7. J. Heller, Use of polymers in controlled release of active agents, in: J.R. Robinson, V. H.L. Lee (Eds.), Controlled Drug Delivery - Fundamentals and Applications, (Drugs and the Pharmaceutical Sciences), 2nd, vol. 29, Marcel Dekker, Inc., New York, 1987, pp. 179-212.
8. H. Santos, F. Veiga, M.E. Pina, J.J. Sousa, Compaction, compression and drug release characteristics of xanthan gum pellets of different compositions, Eur. J. Pharm. Sci. 21 (2004) 271-281.
9. S.M. Al-Saidan, Y.S.R. Krishnaiaha, V. Satyanarayanab, P. Bhaskarc, R.S. Karthikeyan, Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug, Eur. J. Pharm. Biopharm. 58 (2004) 697-703.
10. G. Shlieout, G. Zessin, Investigation of ethyl cellulose as a matrix former and a new method to regard and evaluate the compaction data, Drug Dev. Ind. Pharm. 22 (1996) 313-319.
11. M.J. Tobyn, J.N. Staniforth, A.R. Baichwal, T.W. McCall, Prediction of physical properties of a novel polysaccharide controlled release system, Int. J. Pharm. 128 (1996) 113-122.
12. K. Chikhalikar, S. Moorkath, Carbopol Polymers: A versatile range of polymers for pharmaceutical applications, Pharmabiz, 2002.
13. N.K. Ebube, A.B. Jones, Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers, Int. J. Pharm. 272 (2004) 19-27.
14. Rajan K Verma, Sanjay verma 'Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Europian journal of Pharmaceutics and Biopharmaceutics 57 (2004)513-525
15. Higuchi T. and Conners K.A., Phase solubility techniques. Adv. Anal. Chem., Instrum., 4 (1965) 117 212.
16. Bibby, D. C., Davies, N. M., & Tucker, I. G. (2000). Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. International Journal of Pharmaceutics, 197, 1-11
17. Rajeswari Challa, Alka ahuja, Javed ali and R.K.Khar , Cyclidextrin in drug delivery: An updated review. AAPS Pharmscitech 2005 '6 (2).
18. AArchontaki , M.V. Vertzoni 1, M.H. Athanassiou-MalakiStudied the Inclusion complexes of bromazepam with and hydroxypropyl-cyclodextrins- The solubility of bromazepam increased linearly as a function of concentration for both b and b-hydroxypropyl-cyclodextrins.